Literature DB >> 8484669

Identification of tissue inhibitor of metalloproteinase-2 (TIMP-2)-progelatinase complex as the third metalloproteinase inhibitor peak in rheumatoid synovial fluid.

T E Cawston1, H F Bigg, I M Clark, B L Hazleman.   

Abstract

The metalloproteinases are a family of enzymes that can degrade all the components of the extracellular matrix. These potent enzymes are often found in proenzyme forms and require activation before the substrate can be digested. To prevent unlimited connective tissue destruction a number of inhibitors exist to limit their activity. In a previous study it was found that metalloproteinases in proenzyme form and metalloproteinase inhibitors were often present in rheumatoid synovial fluids. Two of these inhibitors were identified in rheumatoid synovial fluid as alpha 2 macroglobulin and tissue inhibitor of metalloproteinase (TIMP), the specific metalloproteinase inhibitor. A third inhibitory peak was unidentified. In the study reported here it was shown that this third inhibitor can be purified using gelatin-Sepharose chromatography and consists of TIMP-2 bound to progelatinase (relative molecular weight 72,000) in a similar way to that found in concentrated connective tissue culture medium. The importance of these proteinase inhibitors in synovial fluid is discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8484669      PMCID: PMC1005013          DOI: 10.1136/ard.52.3.177

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  28 in total

1.  Preferential binding of collagenase to alpha 2-macroglobulin in the presence of the tissue inhibitor of metalloproteinases.

Authors:  T E Cawston; E Mercer
Journal:  FEBS Lett       Date:  1986-12-01       Impact factor: 4.124

2.  Purification of a metalloproteinase inhibitor from human rheumatoid synovial fluid.

Authors:  E Mercer; T E Cawston; M de Silva; B L Hazleman
Journal:  Biochem J       Date:  1985-11-01       Impact factor: 3.857

3.  Inhibition of tumor cell collagenolytic activity by bovine endothelial cells.

Authors:  Y A DeClerck; W E Laug
Journal:  Cancer Res       Date:  1986-07       Impact factor: 12.701

Review 4.  Regulation of the mammalian collagenases.

Authors:  E D Harris; H G Welgus; S M Krane
Journal:  Coll Relat Res       Date:  1984-12

5.  Metalloproteinases and collagenase inhibitors in rheumatoid synovial fluid.

Authors:  T E Cawston; E Mercer; M de Silva; B L Hazleman
Journal:  Arthritis Rheum       Date:  1984-03

6.  The interaction of purified rabbit bone collagenase with purified rabbit bone metalloproteinase inhibitor.

Authors:  T E Cawston; G Murphy; E Mercer; W A Galloway; B L Hazleman; J J Reynolds
Journal:  Biochem J       Date:  1983-05-01       Impact factor: 3.857

7.  Purification of pig synovial collagenase to high specific activity.

Authors:  T E Cawston; J A Tyler
Journal:  Biochem J       Date:  1979-12-01       Impact factor: 3.857

8.  Primary structure and cDNA cloning of human fibroblast collagenase inhibitor.

Authors:  D F Carmichael; A Sommer; R C Thompson; D C Anderson; C G Smith; H G Welgus; G P Stricklin
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

9.  A synthetic peptide metalloproteinase inhibitor, but not TIMP, prevents the breakdown of proteoglycan within articular cartilage in vitro.

Authors:  H J Andrews; T A Plumpton; G P Harper; T E Cawston
Journal:  Agents Actions       Date:  1992-09

10.  The interaction of alpha 2-macroglobulin with proteinases. Characteristics and specificity of the reaction, and a hypothesis concerning its molecular mechanism.

Authors:  A J Barrett; P M Starkey
Journal:  Biochem J       Date:  1973-08       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.